483
Friese, DavidFriese, David – FDA 483, Nov 2, 2021
Record Details
During an inspection, David Friese was cited for administering a prohibited drug, sulfamenthazine, in an extralabel manner to lactating dairy cattle. Additionally, the firm failed to maintain adequate treatment records for animals, specifically lacking details on treated animals, dates, drugs, dosages, and withdrawal dates. These observations indicate significant deficiencies in animal drug management and record-keeping practices.
View Company Profile
ID · 5d0cb988-113d-4523-aadb-7230d0f2241c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.